Papers

5

Total Citations

88

H-Index

4

About

Raymon H. Grogan is a leading endocrine surgeon whose work has reshaped the surgical management of thyroid, parathyroid, and adrenal diseases. His research centers on defining and advancing minimally invasive and robotic-assisted techniques, with a focus on improving patient outcomes and clarifying surgical terminology. Grogan’s major contributions include critically evaluating the indications and drawbacks of robotic endocrine surgery, as demonstrated in his highly cited 2018 paper (34 citations), and providing essential clarity to the field through his 2014 work defining “minimally invasive parathyroidectomy” (22 citations). He has also assessed the current status of robotic adrenalectomy in the United States (20 citations), highlighting its growing role alongside the laparoscopic gold standard. Beyond these contributions, Grogan has authored comprehensive chapters on thyroid surgery, reflecting his deep expertise in the management of thyroid cancer, a disease whose incidence continues to rise globally. His work has been instrumental in guiding surgeons toward safer, more effective, and evidence-based approaches, making him a respected voice in the evolution of modern endocrine surgery.

Research Focus

Key Achievements

4
H-Index
5
Papers
88
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Robot-Assisted Endocrine Surgery: Indications and Drawbacks
34 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Baylor College of Medicine, University of Chicago, St. Luke's Hospital, University of California, San Francisco

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago